Amphotericin B

Amphotericin B is a broad-spectrum antifungal drug used for serious fungal infections in Microbiology. It kills fungi by binding ergosterol in their cell membranes and damaging membrane integrity.

What is amphotericin B?

Amphotericin B is an antifungal drug in Microbiology that is used when a fungal infection is severe, invasive, or hard to treat. It is famous for being powerful, but also for being rough on the body, so it is often reserved for dangerous infections rather than routine ones.

Its main target is ergosterol, the sterol that fungi use in their cell membranes. Human cells use cholesterol instead, so amphotericin B can tell fungal membranes apart from human membranes. Once the drug binds ergosterol, it disrupts membrane structure and can form pores or channels that let ions leak out. That loss of membrane control damages the fungal cell and can lead to death.

This mechanism is different from drugs that block fungal growth by slowing cell wall synthesis or stopping fungal metabolism. Amphotericin B acts more directly on the membrane itself, which is part of why it can work against a wide range of fungi. In class, you will often see it connected to serious infections caused by organisms like Candida and Aspergillus, especially when the infection has spread beyond a small local site.

The tradeoff is toxicity. Because amphotericin B can also interact with human cell membranes to some extent, it can cause major side effects such as fever, chills, kidney injury, and electrolyte problems. That is why it is often called a drug of last resort. When a fungus is threatening a patient’s life, clinicians may accept those risks because the drug is still one of the strongest options available.

Formulation matters too. Liposomal amphotericin B packages the drug in fat-based particles, which helps reduce some of the toxicity while keeping antifungal activity. In Microbiology, that detail shows how drug design can change the balance between effectiveness and side effects without changing the core target. You may also see amphotericin B given intravenously for systemic disease, since deep infections need drug levels throughout the body rather than just at the skin or a mucosal surface.

Why amphotericin B matters in MICROBIO

Amphotericin B shows how Microbiology links organism structure to drug action. If you know fungi have ergosterol in their membranes, you can predict why a drug that binds ergosterol can be effective and why it will not work the same way against bacteria or viruses.

It also gives you a clean example of the clinical tradeoffs in antimicrobial therapy. The drug is broad and powerful, but serious toxicity means it is not a casual choice. That makes it a useful case for understanding why treatment decisions depend on infection severity, patient condition, and fungal species.

This term also connects to respiratory mycoses, where invasive Aspergillus or other serious fungal infections can become life-threatening in people with weak immune defenses. In those cases, the mechanism and side effects are part of the explanation for why treatment choices can be urgent and complicated.

In lab, quiz, or case-based questions, amphotericin B often shows up as a mechanism question, a drug comparison, or a treatment decision. If you can explain what it binds, what that does to the membrane, and why liposomal formulations were developed, you have the main ideas covered.

How amphotericin B connects across the course

Ergosterol

Ergosterol is the membrane sterol amphotericin B targets. If you remember that fungi rely on ergosterol instead of cholesterol, the drug’s selectivity makes more sense. A question may ask you to connect the presence of ergosterol with antifungal effectiveness, or to explain why membrane-targeting drugs can be toxic but still useful.

Liposomal Formulation

Liposomal amphotericin B is a packaging strategy that reduces some of the drug’s toxicity. The active antifungal still reaches the infection, but the delivery system can limit how much free drug interacts with human tissues. In Microbiology, this is a good example of how formulation changes side effects without changing the main target.

Candida

Candida is one of the fungi commonly treated with amphotericin B when the infection is severe or invasive. The connection matters because not every Candida infection needs this drug, but serious bloodstream or deep tissue cases may require a stronger antifungal. This helps you connect organism identity to treatment choice.

Antifungal Resistance

Antifungal resistance explains why some infections become harder to treat and why broad agents like amphotericin B still matter. If a fungus is less sensitive to other drugs, clinicians may rely on a membrane-targeting option. This relationship comes up in treatment discussions, especially when comparing first-line therapy with backup choices.

Is amphotericin B on the MICROBIO exam?

A quiz or case question may give you a patient with a systemic fungal infection and ask which drug targets ergosterol. Your job is to recognize amphotericin B as the membrane-binding antifungal, then connect that mechanism to why it is reserved for severe disease. If the prompt mentions fever, chills, or kidney toxicity, that is a clue you are dealing with amphotericin B or a liposomal version of it.

In a lab or discussion setting, you might compare antifungal classes and explain why this drug is broad-spectrum but risky. A strong answer names the target, explains the membrane damage, and notes the tradeoff between efficacy and toxicity.

Amphotericin B vs Antifungal Resistance

These are not the same thing. Amphotericin B is a drug, while antifungal resistance is the ability of a fungus to survive treatment. You might discuss resistance when a drug stops working well, but amphotericin B is the medication itself and its mechanism is independent of whether resistance is present.

Key things to remember about amphotericin B

• Amphotericin B is a powerful antifungal used for serious, invasive fungal infections in Microbiology.

• It works by binding ergosterol in fungal cell membranes, which disrupts membrane integrity and can kill the cell.

• Because it can cause major side effects, including kidney toxicity and electrolyte changes, it is often reserved for severe cases.

• Liposomal formulations lower some of the toxicity by changing how the drug is delivered in the body.

• Knowing amphotericin B means knowing both its mechanism and its clinical tradeoff: strong antifungal action with significant risk.

Frequently asked questions about amphotericin B

What is amphotericin B in Microbiology?

Amphotericin B is a broad-spectrum antifungal drug used to treat serious fungal infections. It binds ergosterol in fungal cell membranes, which damages the membrane and can kill the fungus. In Microbiology, it is usually discussed as a powerful but toxic treatment option.

How does amphotericin B work?

It binds to ergosterol, a sterol found in fungal membranes, and disrupts membrane function. That disruption makes the membrane leaky, so ions and other small molecules escape and the fungal cell is damaged. This is why it can be effective against many fungi.

Why is amphotericin B called a drug of last resort?

It can cause serious side effects, especially kidney toxicity, fever, chills, and electrolyte imbalances. Even though it is effective, those risks make it a better choice for severe or life-threatening infections than for mild ones. Liposomal formulations were developed to reduce some of that toxicity.

Is amphotericin B used for Candida and Aspergillus?

Yes, it can be used against both Candida and Aspergillus species, especially in serious infections. It is not always the first choice for every case, but it remains an important option when the infection is invasive or when other treatments are not enough.